ASA Grassroots Network

ASA thanks the bipartisan group of lawmakers who have cosponsored the No Surprises Act Enforcement Act. The No Surprises Act protects patients while helping physicians resolve payment disputes, but weak enforcement has let insurers engage in harmful payment practices without real consequences. This new bill strengthens the enforcement provisions that hold insurers accountable for late or missing payments, restoring Congressional intent.

Now we need your help to keep the momentum going. Ask your lawmaker to support the No Surprises Act Enforcement Act:

American Society of Anesthesiologists American Society of Anesthesiologists

On June 27, ASA’s Committee on Rural Access to Anesthesia Care hosted its 2nd annual Rural Perioperative Symposium.

An expert panel explored the operational criteria rural hospitals use to determine which procedures can be performed locally, the challenges of maintaining reliable anesthesia coverage amid workforce and payment pressures, and the guardrails needed to ensure rural patients receive the best possible care.

Nominations for both the Center for Anesthesia and Perioperative Economics (CAPE) and the Center for Anesthesia Workforce Studies (CAWS) are open through July 1. Learn more about these centers and how to get involved:

CAPE and CAWS Nomination Portal See how ASA is working to resolve three key economic issues that are impacting you, explore the resources of ASA's Payment Progress initiative, and test your anesthesia payment literacy!

Following advocacy by ASA and the D.C. Society of Anesthesiologists, the D.C. Department of Health has rejected the misleading phrase “nurse anesthesiologist” from proposed regulations. Their decision reinforces existing law and patient transparency by affirming that “nurse anesthesiologist” is not a legally recognized title in D.C. or anywhere in the United States: https://www.asahq.org/advocacy-and-asapac/fda-and-washington-alerts/washington-alerts/2026/06/asa-applauds-dc-department-of-healths-rejection-of-misleading-nurse-anesthesiologist-phrase

The FDA just approved a new over-the-counter naloxone nasal spray for emergency opioid overdose treatment. ASA has long advocated for expanded community access to naloxone and applauds the FDA's decisive action. Broader access to this life-saving medication is essential to reducing overdose fatalities across the country. Read our full statement here: https://www.asahq.org/advocacy-and-asapac/fda-and-washington-alerts/washington-alerts/2026/06/asa-welcomes-fda-approval-of-newest-over-the-counter-naloxone-nasal-spray